Browsing: US FDA

2 weeks ago

2 weeks ago Granules India Voluntarily Halts Production at Gagillapur Plant Following US FDA Observations

3 weeks ago

3 weeks ago Gland Pharma Receives EIR from US FDA for Dundigal Facility

4 weeks ago

4 weeks ago Lupin’s Subsidiary Apotex Secures US FDA Approval for Mirabegron

4 weeks ago Caplin Steriles Receives US FDA EIR with Zero Observations: A Positive for Caplin Point Laboratories

1 month ago

1 month ago Aarti Drugs Receives US FDA EIR for Manufacturing Facility

2 months ago

2 months ago Aurobindo Pharma’s Unit V Inspection: Two Observations Issued

2 months ago Glenmark Pharmaceuticals Launches Lacosamide Oral Solution in US Market

2 months ago Granules India Responds to US FDA Observations

3 months ago

3 months ago Granules India’s Unit V Facility Receives Positive US FDA Inspection

4 months ago

4 months ago Granules India Secures US FDA Approval for Bupropion Hydrochloride Extended-Release Tablets

Enable Notifications OK No thanks